NPTX2 and neoplasm: The potential association between circulating NPTX2 methylation levels and other circulating tumor biomarkers, such as RAS mutational status and RAS mutant allele fraction in cfDNA, CA19-9 levels or cfDNA concentration, was determined in all 95 liquid biopsy samples.